Blood Pressure最新文献

{"title":"Evaluation of time delay between discovery of a high blood pressure in a health screening survey and hypertension diagnosis.","authors":"Hassan Imam,&nbsp;Johan Sundström,&nbsp;Lars Lind","doi":"10.1080/08037051.2020.1782726","DOIUrl":"https://doi.org/10.1080/08037051.2020.1782726","url":null,"abstract":"<p><strong>Purpose: </strong>Early treatment of hypertension is important to reduce adverse cardiovascular outcomes. The aim of this study was to investigate the time delay from detection of a high blood pressure in a health screening survey to hypertension diagnosis in primary care.</p><p><strong>Materials and methods: </strong>Seventy years old inhabitants in the Uppsala County were randomly invited to the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. We found 409 individuals without antihypertensive treatment with a blood pressure >140/90 mmHg, being the average of three recordings measured after 30 min rest in a supine position. These individuals were recommended to ask their primary care physician to further investigate this finding.</p><p><strong>Results: </strong>During 10 years of follow-up, 285 of them (70%) received a hypertension diagnosis. The mean time to diagnosis was 5 (SD 2) years. The chance of receiving a diagnosis of hypertension during the follow-up period in this group with elevated blood pressure at baseline was related to the systolic blood pressure (OR 1.04 per 1 mmHg, 95%CI 1.02-1.04), the BMI (OR 1.06 per 1 kg/m², 95%CI 1.01-1.12), and statin use (OR 3.76, 95%CI 1.35-10.3) at the health survey, but was not significantly related to sex, prevalence of diabetes, or use of salicylic acid. No significant interaction between sex and systolic blood pressure regarding hypertension diagnosis was observed.</p><p><strong>Conclusion: </strong>In conclusion, when an elevated blood pressure was discovered in elderly persons at a health screening, 70% of those received a hypertension diagnosis within 10 years, with a mean time to diagnosis of 5 years. Health care actions should be enforced to shorten this time lag both in terms of information to the individuals, as well as the handling of this patient group in primary care.</p>","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037051.2020.1782726","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38105720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Systemic vascular resistance predicts the development of hypertension: the cardiovascular risk in young Finns study.","authors":"Emilia Kähönen,&nbsp;Leo-Pekka Lyytikäinen,&nbsp;Heikki Aatola,&nbsp;Teemu Koivistoinen,&nbsp;Atte Haarala,&nbsp;Kalle Sipilä,&nbsp;Markus Juonala,&nbsp;Terho Lehtimäki,&nbsp;Olli T Raitakari,&nbsp;Mika Kähönen,&nbsp;Nina Hutri-Kähönen","doi":"10.1080/08037051.2020.1783992","DOIUrl":"https://doi.org/10.1080/08037051.2020.1783992","url":null,"abstract":"<p><strong>Purpose: </strong>To study whether systemic hemodynamics, especially systemic vascular resistance, predicts the development of hypertension and improves the risk prediction of incident hypertension beyond common risk factors in the risk models in young adults.</p><p><strong>Materials and methods: </strong>Typical risk factors for hypertension in the risk prediction models (systolic and diastolic blood pressure, parental history of hypertension, age, sex, body-mass index, smoking), laboratory values (high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, glucose, insulin, C-reactive protein), heart rate (HR), stroke index (SI), and systemic vascular resistance index (SVRI) calculated by whole-body impedance cardiography were evaluated in 2007 and blood pressure in 2011 in 1293 Finnish adults (aged 30-45 years; females 56%; <i>n</i> = 1058 normotensive in 2007).</p><p><strong>Results: </strong>Of hemodynamic variables, SVRI and HR evaluated in 2007 were independently associated with systolic blood pressure (<i>p</i> < 0.001 and <i>p</i> = 0.047, respectively) and SVRI with diastolic blood pressure measured in 2011 (<i>p</i> = 0.014), and SVRI and HR were independent predictors of incident hypertension (<i>p</i> < 0.001 and <i>p</i> = 0.024, respectively). SVRI was the most significant predictor of incident hypertension independently of other risk factors (odds ratio 2.73 per 1 standard deviation increase, 95% confidence interval 1.93-3.94, <i>p</i> < 0.001). The extended prediction model (including SVRI) improved the incident hypertension risk prediction beyond other risk factors, with an area under the receiver operating characteristic curve of 0.846 versus 0.817 (<i>p</i> = 0.042) and a continuous net reclassification improvement of 0.734 (<i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>These findings suggest that systemic vascular resistance index predicts the incidence of hypertension in young adults and that the evaluation of systemic hemodynamics could provide an additional tool for hypertension risk prediction.</p>","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037051.2020.1783992","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38094706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Results of renal artery revascularization in the post-ASTRAL era with 4 years mean follow-up.","authors":"Karin Zachrisson,&nbsp;Ferid Krupic,&nbsp;Mikael Svensson,&nbsp;Ann Wigelius,&nbsp;Andreas Jonsson,&nbsp;Angeliki Dimopoulou,&nbsp;Anna Stenborg,&nbsp;Gert Jensen,&nbsp;Hans Herlitz,&nbsp;Anders Gottsäter,&nbsp;Mårten Falkenberg","doi":"10.1080/08037051.2020.1756740","DOIUrl":"https://doi.org/10.1080/08037051.2020.1756740","url":null,"abstract":"<p><p><b>Purpose:</b> To investigate contemporary results of percutaneous transluminal renal angioplasty (PTRA).<b>Materials and Methods:</b> A multicentre retrospective study analysing all patients treated with PTRA for primary symptomatic renal artery stenosis (RAS) between 2010 and 2013 at four tertiary centres. Procedures during the preceding four years were counted to evaluate for change in PTRA frequency.<b>Results:</b> The number of PTRA procedures decreased by approximately 50% from 2006 to 2013. Patients treated in the post-ASTRAL period (<i>n</i> = 224) had a significant reduction in mean systolic pressure (168 to 146 mmHg, <i>p</i> < 0.01), diastolic pressure (84 to 76 mmHg, <i>p</i> < 0.01), number of anti-hypertensive drugs (3.54 to 3.05, <i>p</i> < 0.01), and anti-hypertensive treatment index (21.75 to 16.92, <i>p</i> < 0.01) compared to before PTRA. These improvements were maintained at one year and at the last clinical evaluation after a mean follow-up of 4.31 years. Renal function increased transiently without sustained improvement, or deterioration, during later follow-up. Thirteen patients (5.8%) eventually required dialysis, nine of these had eGFR <20 ml/min/1.73 m² before PTRA. There was no difference in outcomes between subgroups differentiated by different indications for PTRA.<b>Conclusion:</b> The frequency of PTRA has decreased, indicating a higher threshold for invasive treatment of RAS in recent years. The reduction in blood pressures, the reduced need for anti-hypertensive medication, and stabilization of renal function over time suggest a clinical benefit for most patients who are now being treated with PTRA.</p>","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037051.2020.1756740","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37897714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Longitudinal trends in the prevalence of hyperuricaemia and chronic kidney disease in hypertensive and normotensive adults.","authors":"Alena Krajčoviechová,&nbsp;Peter Wohlfahrt,&nbsp;Jan Bruthans,&nbsp;Pavel Šulc,&nbsp;Věra Lánská,&nbsp;Claudio Borghi,&nbsp;Renata Cífková","doi":"10.1080/08037051.2020.1763158","DOIUrl":"https://doi.org/10.1080/08037051.2020.1763158","url":null,"abstract":"<p><p><b>The purpose:</b> To evaluate longitudinal trends in the prevalence of hyperuricaemia and chronic kidney disease (CKD) in Czech adults with and without arterial hypertension (HT).<b>Materials and methods:</b> Two independent cross-sectional surveys were performed in 2006-2009 and 2015-2018, each screening involving 1% population random sample of the general population of nine districts of the Czech Republic aged 25-64 years, stratified by age and gender. Hyperuricaemia was defined as serum uric acid ≥ 420 μmol/l in men, and ≥ 360 μmol/l in women. CKD was defined as estimated glomerular filtration rate < 60 ml/min/1.73 m² and/or albumin/creatinine ratio ≥ 3 mg/mmol.Results: Final analyses included 3504 individuals examined in 2006-2009, and 2309 in 2015-2018. The overall prevalence of hyperuricaemia increased from 16.4% to 25.2% in men (<i>p</i> < 0.001), and from 7.6% to 10.9% in women (<i>p</i> < 0.001), whereas the overall prevalence of CKD declined from 6.8% to 3.6% in men (<i>p</i> = 0.001), and from 7.6% to 4.8% in women (<i>p</i> < 0.001). There was no interaction between HT and hyperuricaemia in either gender; the increase in hyperuricaemia prevalence was observed both in hypertensive and normotensive adults and was accompanied by the increased prevalence of abdominal obesity. Contrarily, there was an interaction between HT and CKD in both men (<i>p</i> < 0.001) and women (<i>p</i> = 0.011); the CKD prevalence declined only in hypertensive individuals, specifically in those using antihypertensive medication and was accompanied by the increased use of renin-angiotensin-aldosterone system (RAS) inhibitors and calcium channel blockers (CCBs).<b>Conclusions:</b> Over the period of 10 years, the overall prevalence of hyperuricaemia increased, while the prevalence of CKD decreased. An increase in the prevalence of hyperuricaemia was observed both in hypertensive and normotensive individuals and was accompanied by an increase in the prevalence of abdominal obesity. A decline in the prevalence of CKD was only observed in hypertensive individuals and was accompanied by the increased use of RAS inhibitors and CCBs.</p>","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037051.2020.1763158","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37948977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors associated with increase in blood pressure and incident hypertension in early midlife: the Hordaland Health Study.","authors":"Ester Kringeland,&nbsp;Grethe S Tell,&nbsp;Helga Midtbø,&nbsp;Teresa R Haugsgjerd,&nbsp;Jannicke Igland,&nbsp;Eva Gerdts","doi":"10.1080/08037051.2020.1762070","DOIUrl":"https://doi.org/10.1080/08037051.2020.1762070","url":null,"abstract":"<p><p><b>Purpose:</b> We aimed to identify sex-specific factors associated with increase in blood pressure (BP) and incident hypertension in early midlife.<b>Materials and methods:</b> 2,008 women and 1,610 men aged 40-43 years were followed for six years in the Hordaland Health Study. Participants taking antihypertensive medication at baseline were excluded. High-normal BP was defined as baseline BP 130-139/85-89 mmHg, and incident hypertension as BP≥140/90 mmHg or use of antihypertensive medication at follow-up.<b>Results:</b> During follow-up, an increase in systolic (SBP) and diastolic (DBP) BP was observed in 54% and 30% of women vs. 44% and 41% of men, respectively (both <i>p</i><0.001). In both sexes higher baseline body mass index (BMI) and increases in BMI and serum lipids were associated with increases in SBP and DBP during follow-up (all <i>p</i><0.05). Incident hypertension was more common in men (14 vs.11%, <i>p</i><0.01), and predicted by higher BMI and high-normal BP at baseline in both sexes, and by higher serum triglyceride level in women (all <i>p</i><0.01). <b>Conclusion:</b> In the Hordaland Health Study, BP development differed between women and men in early midlife. The main factors associated with BP increase in both sexes were higher BMI, weight gain and increases in serum lipids.</p>","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037051.2020.1762070","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37930023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impending hypertensive emergency is frequently considered in guidelines, but neither defined nor explained.","authors":"Goran Koracevic,&nbsp;Milovan Stojanovic,&nbsp;Dragan Lovic,&nbsp;Dragan Djordjevic","doi":"10.1080/08037051.2020.1769467","DOIUrl":"https://doi.org/10.1080/08037051.2020.1769467","url":null,"abstract":"To the editor,Impending hypertension mediated organ damage (HMOD) is included among hypertensive emergencies (HTN-Es) in numerous contemporary articles [1], books [2] and guidelines [3] but not in ...","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037051.2020.1769467","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37963093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The International Society of Hypertension Guidelines 2020 - a new drug treatment recommendation in the wrong direction?","authors":"Sverre E Kjeldsen, Krzysztof Narkiewicz, Michel Burnier, Suzanne Oparil","doi":"10.1080/08037051.2020.1806494","DOIUrl":"10.1080/08037051.2020.1806494","url":null,"abstract":"","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38284283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy.","authors":"Peter M Okin,&nbsp;Darcy A Hille,&nbsp;Kristian Wachtell,&nbsp;Sverre E Kjeldsen,&nbsp;Stevo Julius,&nbsp;Richard B Devereux","doi":"10.1080/08037051.2020.1782171","DOIUrl":"https://doi.org/10.1080/08037051.2020.1782171","url":null,"abstract":"<p><p><b>Purpose</b>: Hypertensive patients are at increased risk of atrial fibrillation (AF). Although low baseline high density lipoprotein (HDL) cholesterol has been associated with a higher risk of AF, this has not been verified in recent population-based studies. Whether changing levels of HDL over time are more strongly related to the risk of new AF in hypertensive patients has not been examined.<b>Material and methods</b>: Incident AF was examined in relation to baseline and on-treatment HDL levels in 8267 hypertensive patients with no history of AF, in sinus rhythm on their baseline electrocardiogram, randomly assigned to losartan- or atenolol-based treatment. HDL levels at baseline and each year of testing were categorised into quartiles according to baseline HDL levels.<b>Results</b>: During 4.7 ± 1.10 years of follow-up, 645 patients (7.8%) developed new AF. In univariate Cox analyses, compared with the highest quartile of HDL levels (>1.78 mmol/l), patients with on-treatment HDL in the lowest quartile (≤ 1.21 mmol/l) had a 53% greater risk of new AF. Patients with on-treatment HDL in the second and third quartiles had intermediate increased risks of AF. Baseline HDL in the lowest quartile was not a significant predictor of new AF (hazard ratio (HR): 1.14, 95% confidence interval (CI): 0.90-1.43). In multivariable Cox analyses adjusting for multiple baseline and time-varying covariates, the lowest quartile of on-treatment HDL remained associated with a nearly 54% increased risk of new AF (HR: 1.54, 95% CI: 1.16-2.05) whereas a baseline HDL≤ ⩽1.21 mmol/l was not predictive of new AF (HR: 1.01, 95% CI: 0.78-1.31).<b>Conclusion</b>: Lower on-treatment HDL is strongly associated with risk of new AF. These findings suggest that serial assessment of HDL can estimate AF risk better than baseline HDL in hypertensive patients with left ventricular hypertrophy. Future studies may investigate whether therapies that increase HDL can lower risk of developing AF.<u>Clinical Trials Registration</u>: http://clinicaltrials.gov/ct/show/NCT00338260?order=1.</p>","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037051.2020.1782171","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38085560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Subtypes of masked hypertension and target organ damage in untreated outpatients.","authors":"Dong-Yan Zhang,&nbsp;Yi-Bang Cheng,&nbsp;Qian-Hui Guo,&nbsp;Ying Wang,&nbsp;Chang-Sheng Sheng,&nbsp;Qi-Fang Huang,&nbsp;De-Wei An,&nbsp;Ming-Xuan Li,&nbsp;Jian-Feng Huang,&nbsp;Ting-Yan Xu,&nbsp;Ji-Guang Wang,&nbsp;Yan Li","doi":"10.1080/08037051.2020.1763159","DOIUrl":"https://doi.org/10.1080/08037051.2020.1763159","url":null,"abstract":"<p><p><b>Purpose:</b> Masked hypertension (MHT) is characterised as an office normotension in the presence of out-of-office hypertension, and can be further categorised as isolated daytime (dMHT), night-time (nMHT) or day-night MHT (dnMHT) according to the time when hypertension is present. MHT is associated with adverse cardiovascular outcome. However, no previous studies contrasted these MHT subtypes in their associations with target organ damage (TOD).<b>Materials and methods:</b> Consecutive untreated patients referred for ambulatory blood pressure (BP) monitoring to our Hypertension Clinic were recruited. Office and ambulatory BPs were measured using the Omron 7051 and SpaceLabs 90217 monitors, respectively. The BP thresholds of daytime and night-time hypertension were of ≥135/85 mmHg and ≥120/70 mmHg, respectively. We performed various TOD measurements, including carotid-femoral pulse wave velocity (cfPWV), carotid intima-media thickness (cIMT), left ventricular mass index (LVMI) and E/E', estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR).<b>Results:</b> The 1808 participants (mean age, 51 years; women, 52%) included 672 (37.2%) MHT subjects, among whom 123 (18.3%) had dMHT, 78 (11.6%) nMHT, and 471 (70.1%) dnMHT. In all participants as well as patients with office normotension (<i>n</i> = 1222), ambulatory daytime and night-time BPs were similarly associated with all TOD measurements (<i>p</i> ≥ 0.20) after multivariate adjustment. Compared to normotensive subjects (<i>p</i> < 0.05), patients with dMHT had faster cfPWV (7.81 vs. 7.58 m/s) and thicker cIMT (637.6 vs. 610.4 µm), patients with nMHT had thicker cIMT (641.8 vs. 610.4 µm) and increased UACR (0.79 vs. 0.59 mg/mmol), and patients with dnMHT had all worse TOD measures mentioned-above plus elevated eGFR (120.7 vs. 116.8 ml/min/1.73m²).<b>Conclusion:</b> MHT was associated with TOD irrespective of subtype, although TOD varied slightly across these subtypes. The study highlights the importance of controlling both daytime and night-time BP in hypertensive patients.</p>","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037051.2020.1763159","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37927636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of adherence to diuretics and β-blockers by serum drug monitoring in comparison to urine analysis.","authors":"Sabrina Ritscher,&nbsp;Coralie Georges,&nbsp;Cora Wunder,&nbsp;Pierre Wallemacq,&nbsp;Alexandre Persu,&nbsp;Stefan W Toennes","doi":"10.1080/08037051.2020.1763775","DOIUrl":"https://doi.org/10.1080/08037051.2020.1763775","url":null,"abstract":"<p><p><b>Purpose:</b> Toxicological screenings for identifying antihypertensive drugs proved to be a useful tool for assessing adherence. However, misinterpretation may occur in case of highly metabolised drugs with low renal excretion, as well as for drugs with a prolonged detectability. The aim of the present study was to compare a recently developed therapeutic drug monitoring (TDM) method based on serum concentrations to an urine drug detection method for assessing adherence in outpatients.<b>Materials and methods:</b> Corresponding urine and blood samples were obtained at the same time from 26 outpatients without supervised medication. Urine and serum analyses were performed using established high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodologies. Adherence was assumed if drugs were detectable in urine or if serum concentrations were above individually calculated lower dose-related concentrations (DRC) or literature-based therapeutic reference ranges (TRR) used as cut-off, respectively.<b>Results:</b> The identification of analytes in urine as well as the quantitative serum assay were performed for atenolol (<i>n</i> = 6 patients), bisoprolol (<i>n</i> = 8), nebivolol (<i>n</i> = 6), canrenone (<i>n</i> = 6, metabolite of spironolactone), hydrochlorothiazide (<i>n</i> = 12) and furosemide (<i>n</i> = 2). On the basis of drug detectability in urine, adherence was assumed in 88% of prescriptions. In 81% (DRC) and 50% (TRR) of the serum analyses the cut-off value was exceeded, which confirms patients' adherence in a lower number. Differences in adherence rates were found in five patients, mainly for β-blockers.<b>Conclusion:</b> This study suggests that assessment of adherence can be performed more precisely on the basis of serum drug concentrations with individually calculated lower DRC than by using the TRR or qualitative urinalysis.</p>","PeriodicalId":55591,"journal":{"name":"Blood Pressure","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037051.2020.1763775","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37929583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}